Normal and low molecular weight heparins: interaction with human platelets

European Journal of Clinical Investigation - Tập 13 Số 2 - Trang 135-139 - 1983
F. Fabris1, F Fussi1, Alessandra Casonato1, L. Visentin1, Maria Luigia Randi1, Matthew R. Smith1, Antonio Girolami1
1Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua Medical School, Padua, Italy, and Hepar Industries, Franklin, Ohio, U.S.A.

Tóm tắt

Abstract. Porcine mucosal heparin was chemically depolymerized. The depolymerization was stopped at different steps to obtain two low molecular weight (LMW) heparins with a molecular weight of 10 000 and 6000, respectively. The LMW heparins were tested in vitro for anti‐clotting activities and for platelet serotonin release in different systems in comparison with normal heparins, dermatan and heparan sulphate.After addition of various amounts of heparin preparations to washed platelets, no significant release was observed for all tested heparins. On the contrary, different heparins showed an inhibition of serotonin‐release induced by collagen in platelet rich plasma, whereas the ADP‐induced release was increased. The effect on the platelet release appears related to the molecular weight. In fact, it is significant only for normal heparins whereas it is not for LMW heparins. A good relation was observed, also, between anti‐activated factor X activity/antiglobal clotting activity (Xa/APTT) ratio of different heparins and the effect on platelet release.

Từ khóa


Tài liệu tham khảo

Gollub S, 1962, Heparin induced thrombocytopenia in man, J Lab Clin Med, 59, 430

Baird AR, 1977, Arterial thromboembolism in patients receiving systemic heparin therapy. A complication associated with heparin induced thrombocytopenia, J Bone Jt Surg Am, 59, 1961, 10.2106/00004623-197759080-00010

Roberts B, 1965, Heparin a cause of arterial emboli, Surgery, 57, 131

Zucker MB., 1977, Biological aspects of heparin action. Heparin and platelet function, Fed Proc, 36, 47

10.1111/j.1600-0609.1972.tb00973.x

10.1111/j.1365-2141.1974.tb06792.x

Thompson CC, 1973, The potentiation of platelet aggregation and adhesion by heparin in vivo and in vitro, Clin Sci Mol Med, 45, 485

10.1111/j.1365-2141.1977.tb00997.x

10.1111/j.1365-2141.1975.tb01860.x

Lindon J, 1978, Interaction of human platelets with heparinized agarose gel, J Lab Clin Med, 91, 47

10.1016/0049-3848(73)90045-5

Scott JE, 1957, The use of long‐chain quaternary ammonium compounds in the fraction of heparin, Proc Biochem Soc, 67, 7

10.1016/S0008-6215(00)84041-0

FussiF FedeliGF.Oligo‐heteropolysaccharides having a heparin‐like activity method for their preparation and pharmaceutical composition based thereon. Fr Pat no. 7823499 1980.

FussiF.A process for obtaining low molecular weight heparins endowed with elevated pharmacological properties and a product so obtained. US Pat1981; 4.281.108.

FussiF FedeliGF.Natural hexuronil‐hexosamine glycane sulphate: method for preparation and related therapeutical use. US Pat Appl1980; 4230699.

Denson KWE, 1973, The measurement of heparin. A method based on the potentiation of anti‐factor Xa, Thromb Diath Haemor, 30, 471, 10.1055/s-0038-1649125

DavidJL HerionF.Method for measurement of14C‐5HT uptake and release by platelets. In:MannucciPM (ed) Platelets function and thrombosis.Adv Exp Med Biol1972:335–9.

Der Shans GS, 1977, The detection of platelets isoantibodies by membrane immunofluorescence, J Lab Clin Med, 90, 4

10.1055/s-0038-1654301

Yin ET, 1973, Plasma heparin, a unique practical, submicrogram sensitive assay, J Lab Clin Med, 81, 298

10.1016/0049-3848(76)90105-5

Fussi F, 1980, Chemistry and biology of heparin, 535

10.1172/JCI109661

10.1136/jcp.22.1.28

Grottum KA., 1969, Platelet surface charge and aggregation. Effects of polyelectrolytes, Thromb Diath Haemor, 21, 450, 10.1055/s-0038-1653559

10.1159/000214176

Thông tin
Thông tin xuất bản

European Journal of Clinical Investigation

Tập 13 Số 2

135-139

Thông tin tác giả